HEMSOL-ACID CONCENTRATE LIQUID HEMOGRAN ACID CONCENTRATE POWDER, NEPHROSOL-ACETATE CONCENTRATE POWDER, BICARBOSOL-BICARE— 510(k) K982378

Name: FDA 510(k) clearance K982378
Creator: U.S. Food and Drug Administration
Published: 1998-08-26

Substantially Equivalent

Solution Technologies

FDA 510(k) clearance K982378 for HEMSOL-ACID CONCENTRATE LIQUID HEMOGRAN ACID CONCENTRATE POWDER, NEPHROSOL-ACETATE CONCENTRATE POWDER, BICARBOSOL-BICARE, Substantially Equivalent on 1998-08-26. Applicant: Solution Technologies. Device class: 2.

Clearance details

Applicant: Solution Technologies
Product code: Code KPO
Device class: Class 2
Regulation: 21 CFR 876.5820
Advisory panel: Gastroenterology, Urology
Date received: 1998-07-08
Decision date: 1998-08-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: South Ogden, UT, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code KPO

view all

K260799 — Nipro Dry Acid Concentrate Mixer2026-08-19
K253462 — NaturaLyte® Dry Bicarbonate Concentrate (08-4112-2)2026-01-29
K252180 — Bicarby Dialysate RFP-404 (RFP-404-W) +7 more2025-09-09
K243786 — Bicarby Dialysate RFP-402 (RFP-402-G) +7 more2025-04-04
K240920 — HemoCare Bicarbonate Concentrate Set (BCS)2024-07-12

Adverse events under product code KPO

product code KPO

Death: 14
Malfunction: 775
Other: 20
Total: 809

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.

Clearance details

Recent devices under product code KPO

More clearances from Solution Technologies

Adverse events under product code KPO